Alector Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
1.20
0.03
(2.56%)
Volume:
1,166,015
52 week range:
0.87 - 6.78
Market Cap:
119.991M
Company Description:
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the. treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases.